AzTrials
AzTrials

Ventral HerniaCLOSURENCT01719718

The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair

A study testing Closure of hernia defect. and No closure of the hernia defect. in people with Ventral Hernia, run by University Hospital, Ghent at 6 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A multicenter prospective randomized controlled trial comparing closure versus non-closure of the hernia defect between 2 and 5 cm in width using a tissue separating mesh (Physiomesh™) in laparoscopic ventral hernia repair. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ventral Hernia
What is being tested?
Closure of hernia defect. and No closure of the hernia defect.
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
93 participants
Where
6 sitesBelgium
Study dates
Oct 2012to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Written informed consent from the patient or his/her legal representative
  • Ventral or incisional hernia requiring elective surgical repair
  • Diameter between 2 and 5cm in width
  • Midline and flank hernias are eligible

Who cannot join

  • No written informed consent
  • 'Hostile' abdomen, open abdomen treatment
  • Contraindication to pneumoperitoneum
  • Emergency surgery (incarcerated hernia)
  • Parastomal hernia
  • Subxiphoidal hernia
Show all 12Show fewer
  • Subcostal hernia
  • Suprapubic hernia
  • Clean-contaminated or contaminated field
  • Hernia diameter >5cm in width
  • Pregnancy
  • Non-compliance

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

Belgium6 sites
  • Algemeen Stedelijk Ziekenhuis

    Aalst

  • Imelda Hospital

    Bonheiden

  • St Vincentius Hospital

    Deinze

  • Ghent University Hospital

    Ghent, 9000

  • Maria Middelares

    Ghent, 9000

  • Hôpital Mont Godinne

    Namur

Other trials in Belgium

About this study

Official title: The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair.

A multicenter prospective randomized controlled trial comparing closure versus non-closure of the hernia defect between 2 and 5 cm in width using a tissue separating mesh (Physiomesh™) in laparoscopic ventral hernia repair.

Conditions
Ventral Hernia
Being tested
Closure of hernia defect., No closure of the hernia defect.
Keywords
ventral hernia
Medical subject headings
Hernia, Ventral

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Closure of hernia defect.Procedure or surgery

    Laparoscopic ventral hernia repair with closure of the hernia defect (mesh augmentation technique).

  • No closure of the hernia defect.Procedure or surgery

    Conventional laparoscopic ventral hernia repair without closure of the hernia defect (defect bridging technique).

Study groups in NCT01719718
Study groupRoleWhat they receive
ClosureActive comparatorNot described
Receives: Procedure: Closure of hernia defect.
Non-ClosureSham comparatorNot described
Receives: Procedure: No closure of the hernia defect.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Seroma formation after 4 weeks.

    The seroma formation is checked by clinical evaluation.

    Measured: 4 weeks after surgery.

Secondary outcomes (3)
  1. Pain, discomfort and esthetic evaluation after 4 weeks.

    Pain, discomfort and esthetic evaluation is performed after 4 weeks by clinical evaluation and the Visual Analogue Scale.

    Measured: 4 weeks after surgery.

  2. Pain, discomfort and esthetic evaluation after 1 year.

    Pain, discomfort and esthetic evaluation is performed after 1 year by clinical evaluation and the Visual Analogue Scale.

    Measured: 1 year after surgery.

  3. Pain, discomfort and esthetic evaluation after 2 years.

    Pain, discomfort and esthetic evaluation is performed after 2 years by clinical evaluation and the Visual Analogue Scale.

    Measured: 2 years after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2012 (estimated)
  2. Study startOct 2012
  3. Primary completionDec 2015
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
93 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01719718
Sponsor's protocol ID
2012/075
Acronym
CLOSURE
Status last verified
May 2024
First submitted
30 Oct 2012
Last updated
17 May 2024
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Closure of hernia defect. and No closure of the hernia defect. in people with Ventral Hernia, run by University Hospital, Ghent at 6 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Seroma formation after 4 weeks. (time frame: 4 weeks after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in